JPRN-UMIN000023005
Completed
未知
Intravitreal anti-VEGF Therapies for Macular Edema Folowing Retinal Vein Occlusion - Intravitreal anti-VEGF for RVO
ConditionsRetinal vein occlusion
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Retinal vein occlusion
- Sponsor
- Kawasaki Medical School
- Enrollment
- 33
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Intravitreal anti-VEGF therapies for macular edema folowing age-related macular degeneratioage-related macular degenerationJPRN-UMIN000023676Kawasaki Medical School500
Completed
Phase 4
Early anti-VEGF Therapy Intervention for Retinal Vein OcclusioRetinal vein occlusionJPRN-UMIN000026173Kyoto Prefectural Univerisity of Medicine50
Recruiting
Phase 1
Treatment of Diabetic Macular Edema with Intraocular Injection of DexamethasoneMacular EdemaDiabetesH360RBR-59phz5cniversidade Federal de Pernambuco
Not yet recruiting
Phase 2
Treatment of Diabetic macular edema with intravitreal injection of antiangiogenic agents with or without DexamethasoneMacular EdemaDiabetesC19.246.099RBR-7468j4qniversidade Federal de Pernambuco
Completed
Not Applicable
Intravitreal bevacizumab(Avastin) for macular edema secondary to uveitis: 1 year results of a prospective pilot studyMacular edema secondary to uveitis.Other specified retinal disordersIRCT138902113846N1Shiraz University of Medical Sciences30